• 2022
  Domenger A, Choisy C, Baron L, Mayau V, Perthame E, Deriano L, Arnulf B, Bories JC, Dadaglio G, Demangel C, , The Sec61 translocon is a therapeutic vulnerability in multiple myeloma., EMBO Mol Med 2022 Jan; (): e14740.
• 2018
  Marine Oberkampf, Camille Guillerey, Juliette Mouriès, Pierre Rosenbaum, Catherine Fayolle, Alexandre Bobard, Ariel Savina, Eric Ogier-Denis, Jost Enninga, Sebastian Amigorena, Claude Leclerc & Gilles Dadaglio , Mitochondrial reactive oxygen species regulate the induction of CD8+ T cells by plasmacytoid dendritic cells., Nat Commun. 2018 Jun 8;9(1):2241.
• 2018
  Mariana Terra, Marine Oberkampf, Catherine Fayolle, Pierre Rosenbaum, Camille Guillerey, Gilles Dadaglio and Claude Leclerc, Tumor-Derived TGFβ Alters the Ability of Plasmacytoid Dendritic Cells to Respond to Innate Immune Signaling., Cancer Res. 2018 Jun 1;78(11):3014-3026.
• 2016
  Tang A, Dadaglio G, Oberkampf M, Di Carlo S, Peduto L, Laubreton D, Desrues B, Sun CM, Montagutelli X, Leclerc C, B cells promote tumor progression in a mouse model of HPV-mediated cervical cancer, Int. J. Cancer 2016 Sep;139(6):1358-71.
• 2014
  Dadaglio G, Fayolle C, Zhang X, Ryffel B, Oberkampf M, Felix T, Hervas-Stubbs S, Osicka R, Sebo P, Ladant D, Leclerc C, Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responses, J. Immunol. 2014 Aug;193(4):1787-98.
• 2012
  Guillerey C, Mouriès J, Polo G, Doyen N, Law HK, Chan S, Kastner P, Leclerc C, Dadaglio G, Pivotal role of plasmacytoid dendritic cells in inflammation and NK-cell responses after TLR9 triggering in mice, Blood 2012 Jul;120(1):90-9.
• 2008
  Mouriès J, Moron G, Schlecht G, Escriou N, Dadaglio G, Leclerc C, Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation, Blood 2008 Nov;112(9):3713-22.
• 2008
  Bréhin AC, Mouriès J, Frenkiel MP, Dadaglio G, Desprès P, Lafon M, Couderc T, Dynamics of immune cell recruitment during West Nile encephalitis and identification of a new CD19+B220-BST-2+ leukocyte population, J. Immunol. 2008 May;180(10):6760-7.
• 2006
  Schlecht G, Mouriès J, Poitrasson-Rivière M, Leclerc C, Dadaglio G, Purification of splenic dendritic cells induces maturation and capacity to stimulate Th1 response in vivo, Int. Immunol. 2006 Mar;18(3):445-52.
• 2004
  Schlecht G, Garcia S, Escriou N, Freitas AA, Leclerc C, Dadaglio G, Murine plasmacytoid dendritic cells induce effector/memory CD8+ T-cell responses in vivo after viral stimulation, Blood 2004 Sep;104(6):1808-15.
• 2004
  Morón G, Dadaglio G, Leclerc C, New tools for antigen delivery to the MHC class I pathway, Trends Immunol. 2004 Feb;25(2):92-7.
• 2003
  Dadaglio G, Morel S, Bauche C, Moukrim Z, Lemonnier FA, Van Den Eynde BJ, Ladant D, Leclerc C, Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes, Int. Immunol. 2003 Dec;15(12):1423-30.
• 2002
  Dadaglio G, Sun CM, Lo-Man R, Siegrist CA, Leclerc C, Efficient in vivo priming of specific cytotoxic T cell responses by neonatal dendritic cells, J. Immunol. 2002 Mar;168(5):2219-24.
• 1997
  Garcia S, Fevrier M, Dadaglio G, Lecoeur H, Riviere Y, Gougeon ML, Potential deleterious effect of anti-viral cytotoxic lymphocyte through the CD95 (FAS/APO-1)-mediated pathway during chronic HIV infection, Immunol. Lett. 1997 Jun;57(1-3):53-8.
• 1997
  Garcia S, Dadaglio G, Gougeon ML, Limits of the human-PBL-SCID mice model: severe restriction of the V beta T-cell repertoire of engrafted human T cells, Blood 1997 Jan;89(1):329-36.
• 1996
  Garcia S, Dadaglio G, Cilote V, Chenal H, Bondurand A, Gougeon ML, Evidence for an in vivo superantigenic activity in human immunodeficiency virus-infected individuals, Blood 1996 Sep;88(6):2151-61.
• 1994
  Dadaglio G, Garcia S, Montagnier L, Gougeon ML, Selective anergy of V beta 8+ T cells in human immunodeficiency virus-infected individuals, J. Exp. Med. 1994 Feb;179(2):413-24.
• 1993
  Gougeon ML, Dadaglio G, Garcia S, Müller-Alouf H, Roue R, Montagnier L, Is a dominant superantigen involved in AIDS pathogenesis?, Lancet 1993 Jul;342(8862):50-1.